3//SEC Filing
MILLENNIUM PHARMACEUTICALS INC 3
Accession 0001395064-21-000091
CIK 0001845337operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 8:55 PM ET
Size
11.8 KB
Accession
0001395064-21-000091
Insider Transaction Report
Form 3
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Holdings
- 6,470,382(indirect: See Explanation of Responses)
Common Stock
MILLENNIUM PHARMACEUTICALS INC
10% Owner
Holdings
- 6,470,382(indirect: See Explanation of Responses)
Common Stock
Footnotes (2)
- [F1]This statement is being filed jointly by Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc.
- [F2]Takeda Pharmaceutical Company Limited's beneficial ownership of the reported securities is comprised of 6,470,382 shares of Common Stock held by Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc., is a direct, wholly owned subsidiary of Takeda Pharmaceuticals U.S.A. Inc., which is a direct subsidiary of Takeda Pharmaceutical Company Limited (72.70%) and Takeda Pharmaceuticals International AG (27.3%). Takeda Pharmaceuticals International AG is a direct, wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001002637
Filing Metadata
- Form type
- 3
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 8:55 PM ET
- Size
- 11.8 KB